Summary
Lack of transparency or mistakes in collaborations between pharmaceutical companies and patient organisations can seriously harm the credibility of both parties.
Even if the collaboration does not involve financial support, it may still be subject to regulations, for example, in the form of significant non-financial support or indirect support.
Get a clear understanding of the different categories of collaboration and clarify your responsibilities and those of patient organisations, even when the collaboration involves third parties such as agencies and media outlets.
We will review the key elements of the legislation and the LIF Code of Conduct and discuss recent media cases and decisions related to such collaborations. We will also address your specific questions, helping you avoid mistakes in your next collaboration.
Keywords
- Collaboration with patient associations
- Marketing compliance
- ENLI’s Patient Organisation Code
Save information for later
Course leader & lecturers
- Elisabeth Gammelgaard LudvigCourse leaderOwner
Sundhedsagenda - Christian Vinding ThomsenLecturerPartner og Advokat
Loeven Advokatfirma
Is this course for you?
- Patient Relations Managers
- Patient Engagement Managers
- Medical Affairs Managers
- Public Affairs managers
- Promotional compliance managers
What you will learn
- How to identify pitfalls in collaboration with patient organisations
- Your (shared) responsibility for compliance with ENLI rules and applicable legislation, and how to support patient organisations in meeting their obligations
- Key decisions and precedents from ENLI and the Danish Medicines Agency in this area
What your company will get
An employee who
- Understands the rules and requirements for collaborating with patient organisations
- Knows the key requirements from ENLI and Danish legislation
- Can identify risks and avoid common pitfalls
- Contributes to transparent and compliant collaborations in practice
Course calendar
Online session
- Review of the legislation and ENLI’s Code governing collaborations between pharmaceutical companies and patient organizations
- Discussion of recent media cases and decisions made by ENLI and the Danish Medicines Agency
- Q&A
Course information
Literature
Prior to the course you get access to mandatory and/or optional readings via your personal Atrium log-in.
Prerequisites
We recommend min. 1 year’s industry experience
Examination
There is no examination for this course.
Course leader
Sundhedsagenda
Lecturer
Loeven Advokatfirma
You may also be interested in these courses
4 Sep 2026
•
Want to know more or need help?
Contact Client Manager, Laura Enemark Skyum at +45 40 46 58 98
Send me a message